Maa: Australia
Kieli: englanti
Lähde: Department of Health (Therapeutic Goods Administration)
Factor VIII, Quantity: 500 IU; Von willebrand factor, Quantity: 1000 IU
CSL Behring Australia Pty Ltd
Injection, diluent for
Excipient Ingredients: water for injections
Intravenous
500 IU/5 mL
(S1) This Schedule is intentionally blank
Biostate is indicated for - the treatment and prophylaxis of haemorrhage or surgical bleeding in VWD when desmopressin (DDAVP) treatment alone is ineffective or contraindicated - the treatment and prophylaxis of bleeding associated with factor VIII deficiency due to haemophilia A.
Visual Identification: Clear, colourless solution, free from visible particles; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius
Listed (Export Only)
2022-06-08